Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement
New York, New York--(Newsfile Corp. - December 4, 2025) - Emerging Growth Research today issued a flash report on OSR Holdings, Inc. (NASDAQ: OSRH), reaffirming its Buy-Emerging rating and 12-month price target of $10.00, representing approximately 1,487% upside from the Company's December 3rd closing price of $0.63.The flash report highlights a major non-binding licensing term sheet announced by OSRH with BCM Europe AG (BCME) valued at $815 million for the global development and...
2025-12-04 3:19 PM EST
Emerging Growth Research Initiates Coverage on First Phosphate Corp. with a Buy Rating and C$4.93 Price Target
New York, New York--(Newsfile Corp. - December 4, 2025) - Emerging Growth Research today announced the initiation of coverage on First Phosphate Corp. (CSE: PHOS) (OTCQB: FRSPF) (FSE: KD0), establishing a Buy rating with a 12-month price target of C$4.93, representing approximately 467% upside from the Company's recent closing price of C$0.87 on December 3rd, 2025.The initiation report positions First Phosphate as a uniquely advantaged Western phosphate platform specifically designed for the...
2025-12-04 9:00 AM EST
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q3:25 Results
New York, New York--(Newsfile Corp. - December 1, 2025) - Emerging Growth Research today announced the release of its Q3:25 quarterly update on SBC Medical Group Holdings, Inc. (NASDAQ: SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing significant upside from the Company's recent closing price of $3.57 on November 28, 2025.The quarterly update highlights SBC's sequential stabilization in revenue and operating profit during Q3:25, strong...
2025-12-01 2:35 PM EST
Emerging Growth Research Releases Q3 2025 Update Report on 22nd Century Group
New York, New York--(Newsfile Corp. - November 26, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), highlighting the Company's now cash-rich balance sheet, full debt repayment, settlement of a $9.5 million insurance case, and stabilization of its Contract Manufacturing Operations (CMO). The updated report also reflects management's revised outlook for EBITDA breakeven, now expected in Q3 2026.Key Highlights from the...
2025-11-26 10:21 AM EST
Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target
New York, New York--(Newsfile Corp. - October 20, 2025) - Emerging Growth Research today announced the initiation of coverage on OSR Holdings, Inc. (NASDAQ: OSRH) with a Buy-Emerging rating and a 12-month price target of $10.00, representing over 1,600% upside from the Company's recent closing price of $0.58.The initiation report highlights OSR Holdings' innovative biotech portfolio, expanding 4th-party logistics (4PL) business, and pending acquisition of Woori IO, a noninvasive glucose...
2025-10-20 11:40 AM EDT
Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target
New York, New York--(Newsfile Corp. - October 17, 2025) - Emerging Growth Research today announced the initiation of coverage on Immuron Limited (Nasdaq: IMRN) with a Buy-Extended rating and a 12-month price target of $4.00, representing over 80% upside from the Company's recent closing price of $2.20.The initiation report highlights Immuron's proprietary polyclonal antibody platform, strong revenue growth from its over-the-counter product Travelan®, and an expanding clinical pipeline...
2025-10-17 11:07 AM EDT
Emerging Growth Research Initiates Coverage on SBC Medical Group Holdings, Inc. with Buy-Extended Rating and $9.00 Price Target
New York, New York--(Newsfile Corp. - September 4, 2025) - Emerging Growth Research today announced the initiation of coverage on SBC Medical Group Holdings, Inc. (NASDAQ: SBC) with a Buy-Extended rating and a 12-month price target of $9.00, more than double the Company's recent closing price of $4.06.The initiation report highlights SBC's dominant position in Japan's cosmetic treatment industry, its strong cash position, and growing global expansion strategy, while also acknowledging...
2025-09-04 9:00 AM EDT
Emerging Growth Research Releases Q2 2025 Update Report on 22nd Century Group
New York, New York--(Newsfile Corp. - August 22, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q2 2025 results. The report reflects ongoing operational restructuring under new management and revised outlook for EBITDA breakeven pushed to Q2 2026 due to slower-than-expected CMO stabilization and VLN® rollout timing.22nd Century Group Q2 2025 Financial Highlights:Q2 2025 revenue of $4.1...
2025-08-22 3:17 PM EDT
Emerging Growth Research Releases Q1 2025 Update Report on 22nd Century Group
New York, New York--(Newsfile Corp. - May 21, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q1 2025 results. The report reflects the continued operational progress made under new management and the outlook for meaningful financial improvement in 2025.22nd Century Group Q1 2025 Financial Highlights:Q1 2025 revenue of $6.0 million, up 48% from Q4 2024Q1 2025 gross profit improved to $(0.6)...
2025-05-21 9:00 AM EDT
Emerging Growth Research Releases Quarterly Update Report on 22nd Century Group (XXII)
Sheridan, Wyoming--(Newsfile Corp. - April 10, 2025) - Emerging Growth Research is pleased to release its latest quarterly update on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q4 2024 results. The report reflects the continued operational progress made under new management and the outlook for meaningful financial improvement in 2025.To read the full report, please visit: http://www.EmergingGrowth.com/profile/xxii/Q4 2024 Financial Highlights:Revenue was $4.0 million,...
2025-04-10 9:00 AM EDT
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII)
Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company has made significant strides in its operational and financial restructuring under new management, with only the warrant overhang remaining to be addressed. To read this report, please visit XXII's landing page on the Emerging Growth website, located here:...
2025-02-19 9:00 AM EST